Crinetics Pharmaceuticals (CRNX) Capital Expenditures (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Capital Expenditures came in at $464000.0 in Q1 2026, up 75.76% year-on-year from $264000.0 in Q1 2025, and down 91.87% quarter-over-quarter from $5.7 million in Q4 2025.
Crinetics Pharmaceuticals has reported Capital Expenditures for 10 years, with the latest figure at $464000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 75.76% year-over-year to $464000.0; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 51.32% YoY), and the FY2025 full-year result was $5.8 million, up 49.9% from the prior year.
- Capital Expenditures for Q1 2026 stood at $464000.0, down from $5.7 million in the prior quarter.
- The five-year high for Capital Expenditures was $5.7 million in Q4 2025, with the low at -$4.4 million in Q3 2025.
- Average Capital Expenditures over 5 years is $741058.8, with a median of $464000.0 recorded in 2026.
- Year-over-year, Capital Expenditures jumped 8766.67% in 2022 and tumbled 930.3% in 2025.
- Tracing CRNX's Capital Expenditures over 5 years: stood at $1.6 million in 2022, then plunged by 280.51% to -$2.9 million in 2023, then soared by 135.72% to $1.0 million in 2024, then jumped by 454.42% to $5.7 million in 2025, then slumped by 91.87% to $464000.0 in 2026.
- The last three Capital Expenditures figures came in at $464000.0 (Q1 2026), $5.7 million (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 464,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464,000.00 |
| Mar 31, 2026 | 464,000.00 |
| Dec 31, 2025 | 5.71 Mn |
| Dec 31, 2025 | 5.71 Mn |
| Sep 30, 2025 | -4.38 Mn |
| Sep 30, 2025 | -4.38 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 264,000.00 |
| Mar 31, 2025 | 264,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 528,000.00 |
| Sep 30, 2024 | 528,000.00 |
| Jun 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 168,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | -2.88 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 237,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 1.60 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | -640,000.00 |
| Sep 30, 2022 | -640,000.00 |
| Jun 30, 2022 | 613,000.00 |
| Jun 30, 2022 | 613,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Mar 31, 2022 | 87,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 418,000.00 |
| Sep 30, 2021 | 418,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Jun 30, 2021 | -21,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 17,000.00 |
| Dec 31, 2020 | 17,000.00 |
| Sep 30, 2020 | 97,000.00 |
| Sep 30, 2020 | 97,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 60,000.00 |
| Mar 31, 2020 | 60,000.00 |
| Dec 31, 2019 | -352,000.00 |
| Dec 31, 2019 | -352,000.00 |
| Jun 30, 2019 | 56,000.00 |
| Jun 30, 2019 | 56,000.00 |
| Mar 31, 2019 | 408,000.00 |
| Mar 31, 2019 | 408,000.00 |
| Dec 31, 2018 | 913,000.00 |
| Dec 31, 2018 | 913,000.00 |
| Sep 30, 2018 | 94,000.00 |
| Sep 30, 2018 | 94,000.00 |
| Jun 30, 2018 | -15,000.00 |
| Jun 30, 2018 | -15,000.00 |
| Mar 31, 2018 | 67,000.00 |
| Mar 31, 2018 | 67,000.00 |
| Dec 31, 2017 | 231,000.00 |
| Dec 31, 2017 | 231,000.00 |
| Sep 30, 2017 | 18,000.00 |
| Sep 30, 2017 | 18,000.00 |